跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确研究异质个体化治疗效应与最优治疗规则,并以跨亚群的治疗决策为核心目标,直接关联因果推断。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Chengchun Shi
Rui Song
Wenbin Lu
Bo Fu

异质个体化治疗效应下最优治疗决策的最大最小投影学习

研究问题
在各群体边际治疗效应相同、个体化治疗效应存在群体差异时,如何构造对可能来自新亚群的未来患者可靠的单一决策规则?
方法与思路
作者基于各亚群估计的最优治疗规则,提出最大最小投影学习,将统一规则的求解转化为可用内点法计算的二次约束线性规划。
材料陈述的贡献
摘要称该方法建立了估计量的一致性与渐近正态性,并通过数值示例展示可靠性,目标是应对跨亚群的治疗反应异质性。
阅读关注点
应核对共同边际治疗效应假设、亚群治疗规则的识别与估计条件,以及最大最小准则如何约束对新亚群的适用范围。
阅读边界
仅据所给 Crossref 摘要;识别条件、可靠性的具体定义及数值比较均未说明,不能将结论推广到任意群体变化。

原文摘要

Summary A salient feature of data from clinical trials and medical studies is inhomogeneity. Patients not only differ in baseline characteristics, but also in the way that they respond to treatment. Optimal individualized treatment regimes are developed to select effective treatments based on patient's heterogeneity. However, the optimal treatment regime might also vary for patients across different subgroups. We mainly consider patients’ heterogeneity caused by groupwise individualized treatment effects assuming the same marginal treatment effects for all groups. We propose a new maximin projection learning method for estimating a single treatment decision rule that works reliably for a group of future patients from a possibly new subpopulation. Based on estimated optimal treatment regimes for all subgroups, the proposed maximin treatment regime is obtained by solving a quadratically constrained linear programming problem, which can be efficiently computed by interior point methods. Consistency and asymptotic normality of the estimator are established. Numerical examples show the reliability of the methodology proposed.

笔记与分组